NKCL Master

News

EN
CN
KR

EN

NKCL Bio Group Inc., Acquired Manufacturing Permit for Advanced Biopharmaceuticals

As part of the policy pledge of the new government in 2022, in relation to fostering the advanced bioindustry, which is attracting attention as a growth engine industry, pharmaceutical and bio companies are announcing the latest biopharmaceutical manufacturing permits. This is interpreted as ‘legal ...

NKCL | 2023.01.25 | 조회 496

Personalized Immune Care Platform, NKCL Bio Group

The prolonged COVID-19 has increased the importance of virus research worldwide. We have been affected by many viruses. Colds, which are now simply recognized, are also viruses. However, the perception of the virus is changing as we go through COVID-19, and the state's inability to play its role due ...

NKCL | 2022.12.13 | 조회 575

NKCL Bio Group won the Grand Prize at the Minister of SMEs and Startups Award for its contribution to the development of the Korean bio industry

NKCL Bio Group Inc. announced on November 25 that it had won the Grand Prize in the ‘Innovation Sector’ award from the Minister of Small and Medium Venture Business. The Ministry of SMEs and Startups said, “NKCL Bio Group was highly evaluated for its contribution to the development of the Korean b...

NKCL | 2022.11.30 | 조회 606

NKCL Bio Group Inc. won the ‘2022 TV Chosun Management Grand Awards’ in two categories

NKCL Bio Group Inc. announced on the 25th that it had won awards in two categories, the Technology Innovation Division and the Innovation Division of the Ministry of SMEs and Startups, at the ‘9th 2022 TV Chosun Management Grand Awards’. It is an awards ceremony hosted by TV Chosun and sponsored by...

NKCL | 2022.11.28 | 조회 667

NKCL Bio Group signed the MOA for Vietnamese market entry with Eco Smart Global

On the 9th, NKCL Bio Group announced that it had signed a business agreement in Vietnam with Eco smart global, which has a business infrastructure in Vietnam, in order to enter the Vietnamese market in earnest. Eco Smart Global is a Korean company specializing in distribution channels that conducts v...

NKCL | 2022.11.10 | 조회 629

NKCL Bio Group, ‘Introduction of NK cell therapy and anti-aging solution program’ at Maeil Business TV’s ‘High Praise Company’

On October 12th, the filming of Maeil Economy TV’s 'High Praise Company' was held at NKCL Bio Group. Maeil Business TV's 'High Praise Company' is a program that delivers useful information by introducing the outstanding technologies of companies leading the Korean economy, such as introducing the un...

NKCL | 2022.10.31 | 조회 195

NKCL Bio Group, gave a speech at ‘BWB 2022’ Conference in the theme of ‘Blockchain Application Model in Bio Industry’

On October 27th (Thursday), NKCLC, a blockchain operated by NKCL Bio Group and Encle Foundation, participated in Blockchain Week in Busan (BWB 2022). BWB 2022, hosted by Busan City and the Busan Blockchain Industry Association, is a blockchain-specialized event to be held following the last year's 'N...

NKCL | 2022.10.31 | 조회 202

NKCLBIO Group Announces ‘Blockchain Application Model in Bio Industry’ at Blockchain Week in Busan (BWB 2022)

NKCLC of NKCL Bio Group Inc. and Encle Foundation announced that they would participate in Blockchain Week in Busan (BWB 2022). BWB 2022 is a blockchain-specialized event held in Busan following last year’s ‘NFT Busan 2021’ and will be held for three days from October 27 (Thu) to 29 (Sat) at BEXCO...

NKCL | 2022.10.25 | 조회 199

NKCL BIO Group Inc. Announced Preclinical Results at 2022 International Conference: Korean Society of Molecular and Cellular Biology

NKCL Biogroup announced that it had presented the preclinical results of NK cell therapy at the '2022 International Conference: The Korean Society for Molecular and Cellular Biology' (KSMCB) on the 30th. The Korean Society for Molecular and Cellular Biology, a world-renowned academic conference on ce...

NKCL | 2022.10.04 | 조회 229

NKCL Bio Group Inc. "Focused on developing therapeutics based on NK immune cells... Expanding the global market"

1. Brief introduction of your company and current status please. Hello. This is Shin, Dong-Hwa, the CEO and Chairman of NKCL Bio Group Inc. NKCL Bio Group Inc.(NKCL Bio Group) is a bio-specialized company that researches and develops NK cell culture technology based on its cell culture technology. NK...

NKCL | 2022.08.30 | 조회 244

[ 1 ] 2 3 4 5 6 7 8 9 10